US FDA Slows eMDR Global Harmonization Phase-In To Give Companies More Time
Executive Summary
After device-makers raised concerns about a looming deadline to adopt new adverse-event reporting codes, FDA has decided to delay updating its electronic Medical Device Reporting (eMDR) system by two months. The update is part of the agency's effort to make it easier to report medical device adverse events across global regulatory jurisdictions.